021921 Frontier Medicines
BioCentury & Getty Images

Emerging Company Profile

Frontier Medicines: tapping binding pockets across the proteome

Emerging Company Profile: UC Berkeley spinout is using its chemoproteomics platform to develop three modalities 

The UC Berkeley spinout is using its chemoproteomics platform to develop three therapeutic modalities.

Feb 19, 2021 | 10:17 PM GMT

Having found “hotspot” binding pockets in more than

Read the full 582 word article

How to gain access

Continue reading with a
two-week free trial.